Prostate Cancer

[unable to retrieve full-text content] Ovarian Cancer: How to Spot Early Signs and What Are Your ...    Healthnews.com

February 17, 2023 3 min read Source/Disclosures Published by: Source: Galsky MD, et al. Abstract 447. Presented at: ASCO Genitourinary Cancers Symposium; Feb. 16-18, 2023; San Francisco. Disclosures: Galsky reports research funding to his institution from, consulting/advisory roles with, or stock or other ownership interests in Aileron Therapeutics, Astellas Pharma, AstraZeneca, Bristol Myers Squibb, Eli Lilly, EMD Serono, Genentech, Gilead Sciences, GlaxoSmithKline, Incyte, Janssen, Merck, Novartis, Pfizer, Rappta Therapeutics, Seagen and other companies. Please see the...

Most men don't regularly talk about their prostate—the walnut-size gland just below the bladder that produces seminal fluid. But considering the statistics surrounding prostate cancer, they should. It's the second most common cancer in males in the United States and one of the leading causes of cancer death among all men. And like many other types of cancer, it has a significant impact on Black communities. The numbers shine a harsh light on racial disparities: Prostate cancer makes up roughly 37% of all newly diagnosed cancer cases in Black men. Black men get prostate cancer at a younger age than men from other groups, and they are more likely to have advanced disease when they are diagnosed. Ultimately, Black men are twice as likely to die from prostate cancer than most other men. Share Did you like reading this story? Click the heart to show your love. ...

Many skin cancers — including cutaneous melanoma — are associated with UV exposure. Yet acral lentiginous melanoma develops only on areas of the body that can't really be protected by sunscreen — and there's no direct link to UV exposure. So, what causes acral lentiginous melanoma? And how is it normally diagnosed and treated? To learn more about this rare skin cancer, we spoke with dermatologist Kelly Nelson, M.D., and melanoma specialist Isabella Glitza Oliva, M.D., Ph.D. What is acral lentiginous melanoma? Nelson: It's a type of skin cancer that only develops on the palms of the hands, the soles of the feet or under the nails. Glitza : It's also very rare. Acral lentiginous melanoma only makes up about 5% of all new melanomas diagnosed each year. What does acral lentiginous melanoma look like? Nelson: Usually, acral lentiginous melanoma can appear as an unevenly pigmented black or brown spot on the palm or sole that looks different from the rest of the ...

Share on Pinterest Men with a family history of prostate cancer may be better equipped to survive this condition. Image credit: Uwe Krejci/Getty Images. Men with prostate cancer who come from families with a history of prostate cancer are significantly more likely to survive, compared with other men. According to the study, men with prostate cancer who also have a first-degree or second-degree relative who has or has had cancer are 15% more likely to survive prostate cancer. The authors of the study suggest that this is due to a heightened awareness of cancer risk and more proactive screening among members of such families. A man's risk of developing prostate cancer increases if he has a family history of prostate cancer. Research has shown that those with a brother or father who had a prostate cancer diagnosis are twice as likely to receive the same diagnosis themselves as men with no family history of this form of cancer. However, according to a new study, men with a family histo...

Investigators identified a significant association between Glasgow prognostic scores (GPS) and overall survival (OS) and progression-free survival (PFS) among patients receiving atezolizumab (Tecentriq) plus carboplatin and etoposide for small cell lung cancer (SCLC), according to findings from a retrospective study published in Frontiers in Oncology. "GPS was identified as a significant predictor after [atezolizumab plus carboplatin and etoposide] therapy for patients with SCLC," the study authors stated. The median PFS and OS from treatment initiation, respectively, were 5.4 months (95% CI, 4.9-5.9) and 15.4 months (95% CI, 11.4-16.8). Additionally, a GPS of 0 or 1 correlated with a significantly better PFS. Patients with a GPS of 0 to 1 had a median PFS of 5.8 months vs 3.8 months for those with a GPS of 2 ( P = .0005). Moreover, the median OS in patients with a GPS of 0 or 1 was 16.5 months vs 8.4 months among those with a GPS of 2 ( P <.0001). "GPS was iden...

Yet many see promise for artificial intelligence to help issues of bias in medical care How we did this Pew Research Center conducted this study to understand Americans' views of artificial intelligence (AI) and its uses in health and medicine. For this analysis, we surveyed 11,004 U.S. adults from Dec. 12-18, 2022. Everyone who took part in the survey is a member of the Center's American Trends Panel (ATP), an online survey panel that is recruited through national, random sampling of residential addresses. This way, nearly all U.S. adults have a chance of selection. The survey is weighted to be representative of the U.S. adult population by gender, race, ethnicity, partisan affiliation, education and other categories. Read more about the ATP's methodology. Here are the questions used for this report, along with responses, and its methodology. This is part of a series of surveys and reports that look at the increasing role of AI in shaping Am...